Table 3.
Control + antibody |
Mutant + Vehicle | Mutant + antibody 1w |
Mutant + antibody 3w |
||
---|---|---|---|---|---|
Left OB | |||||
|
|||||
OB volume (mm3) | 10.3 ± 0.2 | 3.7 ± 0.5*** | 4.0 ± 0.7*** | 3.9 ± 0.4*** | |
Mi to Mi Distance (mm) | 0.54 ± 0.05 | 0.67 ± 0.06* | 0.73 ± 0.07** | 0.69 ± 0.08* | |
Layer to minimum ratio | GL | 1.19 ± 0.05 | 1.06 ± 0.07** | 1.04 ± 0.06*** | 1.01 ± 0.06*** |
Mi | 1.16 ± 0.03 | 1.11 ± 0.10 | 1.11 ± 0.06 | 1.11 ± 0.07 | |
Right OB | |||||
|
|||||
OB volume (mm3) | 10.3 ± 0.3 | 3.8± 0.4*** | 4.0 ± 0.6*** | 3.9 ± 0.5*** | |
Mi to Mi Distance (mm) | 0.51 ± 0.03 | 0.69 ± 0.07*** | 0.71 ± 0.08* | 0.68 ± 0.05** | |
Layer to minimum ratio | GL | 1.15 ± 0.05 | 1.06 ± 0.05** | 1.03 ± 0.02** | 1.07 ± 0.06* |
Mi | 1.16 ± 0.05 | 1.12 ± 0.08 | 1.09 ± 0.07* | 1.12 ± 0.07 |
Mutant treated with vehicle or hAPP antibody vs. control for left and right OB:
p < 0.05
p < 0.01
p <0.001
GL – glomerular layer, Mi – mitral cell layer.